Evidence map›Paper›PMID 42798720›Full record

ArticleFrontiers in pharmacology2026

Inhibitory effects of cold atmospheric plasma-activated solution on cutaneous squamous cell carcinoma.

Jingfei Wang, Zhengyi Zhang, Baochen Cheng, Xinyi Zhao, Tingyi Yin, Tianji Ni, Wenqian Du, Xinyi Liu, Shuo Feng, Ke He and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jingfei WangDepartment of Dermatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Zhengyi ZhangDepartment of Dermatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Baochen ChengDepartment of Dermatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Xinyi ZhaoState Key Laboratory of Electrical Insulation and Power Equipment, Centre for Plasma Biomedicine, Xi'an Jiaotong University, Xi'an, China.
Tingyi YinDepartment of Dermatology, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
Tianji NiState Key Laboratory of Electrical Insulation and Power Equipment, Centre for Plasma Biomedicine, Xi'an Jiaotong University, Xi'an, China.
Wenqian DuDepartment of Dermatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Xinyi LiuDepartment of Dermatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Shuo FengDepartment of Dermatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Ke HeDepartment of Dermatology, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
Jing ZhangDepartment of Dermatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Yan SunDepartment of Dermatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Dehui XuState Key Laboratory of Electrical Insulation and Power Equipment, Centre for Plasma Biomedicine, Xi'an Jiaotong University, Xi'an, China.
Yan ZhengDepartment of Dermatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous squamous cell carcinoma (cSCC) is a common malignant skin neoplasm for which current therapeutic options for advanced and metastatic cases remain limited and are associated with considerable toxicity. Plasma-activated solution (PAS)-prepared by exposing media such as culture medium, water, or phosphate-buffered saline (PBS) to cold atmospheric plasma (CAP)-has emerged as a novel antitumor strategy. In recent years, PAS has garnered increasing attention owing to its advantages over direct CAP application, including ease of storage and clinical administration. In the present study, we investigated the therapeutic potential of PAS in cSCC. In this study, we established an

Indexed as

apoptosiscold atmospheric plasmacutaneous squamous cell carcinomaoxidative stressplasma-activated solution

Identifiers

PMID42798720
PMCPMC13612911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.